Fortrea
Naveen KK is a seasoned professional in clinical drug safety and pharmacovigilance, currently serving as Vice President and Global Head of Safety Services at Fortrea since July 2023. With prior experience as Executive Director and Global Head of Central Monitoring at Labcorp Drug Development, Naveen has extensive expertise in centralized medical data review and safety solutions. A significant portion of Naveen's career was spent at Quintiles, where roles included Senior Director of Risk Based Monitoring and various positions in pharmacovigilance. Naveen's educational background comprises advanced degrees from prestigious institutions, including an Executive PG in Global Business Management from the Indian Institute of Management, Calcutta, an MBA from Sikkim Manipal University, and a medical degree from Jawaharlal Nehru Medical College.
This person is not in the org chart
This person is not in any offices
Fortrea
13 followers
Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development and patient access solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients in need. Fortrea provides phase I-IV clinical trial management, clinical pharmacology, differentiated technology-enabled trial solutions and post-approval services. Fortrea’s solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, exceptional insights and a strong investigator site network. Our talented and diverse team of approximately 19,000 people working in more than 90 countries is scaled to deliver focused and agile solutions to customers globally. Learn more about how Fortrea is becoming a transformative force from pipeline to patient at Fortrea.com.